Cefiderocol: a novel Siderophore cephalosporin against multidrug‐resistant gram‐negative pathogens

JC Abdul‐Mutakabbir, S Alosaimy… - … : The Journal of …, 2020 - Wiley Online Library
Cefiderocol (CFDC),(formerly S‐649266), is a novel injectable siderophore cephalosporin
developed by Shionogi & Co., Ltd., with potent in vitro activity against Gram‐negative …
被引用次数：44 相关文章

Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug-Resistant Gram-Negative Pathogens.

JC Abdul-Mutakabbir, S Alosaimy, T Morrisette… - …, 2020 - europepmc.org
Cefiderocol (CFDC),(formerly S-649266), is a novel injectable siderophore cephalosporin
developed by Shionogi & Co., Ltd., with potent in vitro activity against Gram-negative …

Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug‐Resistant Gram‐Negative Pathogens

JC Abdul‐Mutakabbir, S Alosaimy, T Morrisette… - … : The Journal of Human …, 2020 - infona.pl
Cefiderocol (CFDC),(formerly S‐649266), is a novel injectable siderophore cephalosporin
developed by Shionogi & Co., Ltd., with potent in vitro activity against Gram‐negative …

Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug‐Resistant Gram‐Negative Pathogens.

JC Abdul‐Mutakabbir, S Alosaimy… - …, 2020 - search.ebscohost.com
Abstract Cefiderocol (CFDC),(formerly S‐649266), is a novel injectable siderophore
cephalosporin developed by Shionogi & Co., Ltd., with potent in vitro activity against …

Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug-Resistant Gram-Negative Pathogens

JC Abdul-Mutakabbir, S Alosaimy… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Cefiderocol (CFDC),(formerly S-649266), is a novel injectable siderophore cephalosporin
developed by Shionogi & Co., Ltd., with potent in vitro activity against Gram-negative …

Cefiderocol: a novel siderophore cephalosporin against multidrug-resistant gram-negative pathogens.

JC Abdul-Mutakabbir, S Alosaimy, T Morrisette… - 2020 - cabidigitallibrary.org
Abstract Cefiderocol (CFDC),(formerly S-649266), is a novel injectable siderophore
cephalosporin developed by Shionogi & Co., Ltd., with potent in vitro activity against Gram …